文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

重组人血栓调节蛋白对因肠穿孔接受连续血液透析滤过的脓毒症患者具有附加效应

Recombinant Human Thrombomodulin Has Additive Effects in Septic Patients Undergoing Continuous Hemodiafiltration Due to Intestinal Perforation.
PubMed 文献 · Shock · 2021-01-01
一句话结论在因肠穿孔接受CHDF的脓毒症患者中,加用rhTM可抑制炎症指标、加速血小板恢复、缩短CHDF治疗和ICU入住时间。

本研究比较单用CHDF(n=23)与CHDF联合rhTM(n=21)的脓毒症患者,发现rhTM+组白细胞数、CRP和D-二聚体显著受抑,血小板恢复更快,SOFA和APACHE II评分逐渐降低,CHDF治疗和ICU入住时间缩短,多因素分析显示rhTM是CHDF治疗时间的独立因素。大鼠CLP模型显示rhTM显著改善急性肺损伤并抑制组织巨噬细胞TNF-α产生。结论提示rhTM在CHDF脓毒症患者中具有附加效应。

要点

  • 在因肠穿孔接受CHDF的脓毒症患者中,加用rhTM组白细胞数、CRP和D-二聚体水平较单用CHDF组显著受抑。
  • rhTM+组血小板计数恢复显著快于rhTM-组,DIC评分两组均降低。
  • rhTM+组SOFA和APACHE II评分逐渐降低,CHDF治疗时间和ICU入住时间较rhTM-组缩短。
  • 多因素分析显示rhTM治疗是CHDF治疗时间的独立影响因素。
  • 大鼠CLP模型中rhTM显著改善急性肺损伤,并抑制组织巨噬细胞TNF-α产生(体内和体外)。

适用人群与场景

  • 因肠穿孔导致脓毒症并接受连续血液透析滤过(CHDF)的患者(临床部分)。
  • 大鼠盲肠结扎穿孔(CLP)脓毒症模型(动物部分)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:临床回顾性比较研究(CHDF alone n=23 vs CHDF+rhTM n=21)加动物实验(大鼠CLP模型)。
  • 临床部分:rhTM+组白细胞数、CRP和D-二聚体水平显著受抑,血小板计数恢复显著更快。
  • 临床部分:DIC评分两组均降低;rhTM+组SOFA和APACHE II评分逐渐降低。
  • 临床部分:rhTM+组CHDF治疗时间和ICU入住时间较rhTM-组缩短;多因素分析显示rhTM治疗是CHDF治疗时间的独立因素。
  • 动物部分:CLP诱导的急性肺损伤被rhTM显著改善;组织巨噬细胞TNF-α产生在体内和体外均被rhTM显著抑制。

证据类型、等级与局限

  • 证据类型:临床比较研究(非随机)加动物实验;原文未给出证据等级或推荐强度。
  • 局限:临床部分样本量小(rhTM-组23例,rhTM+组21例),原文未提及是否为单中心或回顾性设计。

对床旁实践的改变

  • 对于因肠穿孔接受CHDF的脓毒症患者,加用rhTM可能抑制炎症指标、加速血小板恢复并缩短CHDF治疗和ICU入住时间,但需注意证据来自小样本非随机比较研究。
  • 动物实验提示rhTM可能改善脓毒症相关急性肺损伤并抑制巨噬细胞TNF-α产生,但尚未在临床中验证。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Disseminated intravascular coagulation (DIC) is associated with high mortality in patients with severe sepsis. The purpose of this study was to investigate the effects of recombinant human thrombomodulin (rhTM) in septic patients undergoing continuous hemodiafiltration (CHDF). Furthermore, effects of rhTM in acute lung injury, the first target organ in sepsis, were investigated using a sepsis model in rats.

METHODS: Clinical laboratory data, and the DIC, Sequential Organ Failure Assessment (SOFA), and Acute Physiologic and Chronic Health Evaluation (APACHE) II scores were compared between patients undergoing CHDF alone (rhTM- group; n = 23 cases) and patients undergoing CHDF treated with rhTM (rhTM+ group; n = 21 cases). Rats underwent cecal ligation and puncture (CLP) treated with or without rhTM, and acute lung injury (ALI) was analyzed. Production of TNF-α by isolated tissue macrophages (Mfs) was assessed.

RESULTS: The numbers of leukocytes, and C-reactive protein and D-dimer levels were significantly suppressed, and platelet counts recovered significantly faster in the rhTM+ group compared with the rhTM- group. The DIC score was reduced in both groups. The SOFA and APACHE II scores gradually reduced in the rhTM+ group. The CHDF treatment and ICU admission periods were shortened in the rhTM+ group compared with the rhTM- group. Treatment of rhTM was an independent factor for CHDF treatment period by multivariate analyses. CLP-induced ALI was significantly improved by rhTM. Increased TNF-α production by tissue Mfs was significantly suppressed by rhTM in vivo and in vitro.

CONCLUSION: Additive effects of rhTM treatment were observed in septic patients undergoing CHDF.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kono H, Hosomura N, Amemiya H, et al. Recombinant Human Thrombomodulin Has Additive Effects in Septic Patients Undergoing Continuous Hemodiafiltration Due to Intestinal Perforation. Shock. 2021. PMID: 33595258. doi:10.1097/SHK.0000000000001750

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。